AlphaCentric Advisors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

AlphaCentric Advisors’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,500	Closed	-$54K	–	231
2020 Q4	$54K	Hold	1,500	–	–	0.02%	179
2020 Q3	$42K	Buy	+1,500	New	+$53.1K	0.02%	118

AlphaCentric Advisors's VIE Position: Q1 2021 in Review

AlphaCentric Advisors sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 1,500 shares — an estimated $54K sold.

AlphaCentric Advisors first reported a position in VIE in Q3 2020 and held it in 2 quarters. The position peaked at $54K in Q4 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

AlphaCentric Advisors reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
AlphaCentric Advisors sold 1,500 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $54K.
AlphaCentric Advisors first reported a position in Viela Bio, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
AlphaCentric Advisors's Viela Bio, Inc. Common Stock position peaked at $54K in Q4 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.